Related Experiment Videos
Gene therapy in epilepsy
1Mario Negri Institute for Pharmacological Research, Milan, Italy. vezzani@marionegri.it
Epilepsy Currents
|August 2, 2005
Summary
Gene and cell therapies using viral vectors like AAV can introduce genes into the brain for long-lasting protein production. These methods, including engineered cells, show potential for treating epilepsy by delivering neuroactive substances.
Area of Science:
- Neuroscience
- Gene Therapy
- Cell Therapy
Background:
- Viral vectors enable stable transduction of neurons for gene delivery.
- Genetically engineered cells can be grafted to produce neuroactive substances in the brain.
Purpose of the Study:
- To explore gene and cell therapy strategies for brain applications.
- To investigate the potential of neuroactive substance delivery for epilepsy therapy.
Main Methods:
- Utilizing adeno-associated virus (AAV) and lentivirus for gene delivery.
- Employing cell grafting with genetically modified cells.
Main Results:
- Viral vectors facilitate long-lasting protein production in neurons.
- Engineered cells can deliver neuroactive peptides, adenosine, and gamma-aminobutyric acid.
Conclusions:
- Gene and cell therapies offer promising avenues for brain interventions.
- Delivery of specific neuroactive agents via these methods holds potential for epilepsy treatment.